Enlong Ma

1.1k total citations
40 papers, 894 citations indexed

About

Enlong Ma is a scholar working on Molecular Biology, Oncology and Complementary and alternative medicine. According to data from OpenAlex, Enlong Ma has authored 40 papers receiving a total of 894 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 14 papers in Oncology and 6 papers in Complementary and alternative medicine. Recurrent topics in Enlong Ma's work include Peptidase Inhibition and Analysis (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Traditional Chinese Medicine Analysis (4 papers). Enlong Ma is often cited by papers focused on Peptidase Inhibition and Analysis (8 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Traditional Chinese Medicine Analysis (4 papers). Enlong Ma collaborates with scholars based in China, Japan and Canada. Enlong Ma's co-authors include Yanchun Li, Jianchun Li, Wei Xiao, Ikuko Kimura, Hiroshi Tsuneki, Minwei Wang, Sizhe Feng, Song Iy Han, Yanchun Li and Xiaonan Wang and has published in prestigious journals such as PLoS ONE, Biochemical and Biophysical Research Communications and IEEE Transactions on Information Theory.

In The Last Decade

Enlong Ma

40 papers receiving 882 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Enlong Ma China 17 409 167 142 108 104 40 894
Hong Xiang Zuo China 21 582 1.4× 196 1.2× 157 1.1× 214 2.0× 86 0.8× 37 1.3k
An-Cheng Huang Taiwan 17 557 1.4× 131 0.8× 128 0.9× 128 1.2× 143 1.4× 20 901
Chunliu Mi China 22 689 1.7× 157 0.9× 122 0.9× 204 1.9× 84 0.8× 41 1.1k
Priya Weerasinghe United States 14 536 1.3× 202 1.2× 227 1.6× 133 1.2× 66 0.6× 18 934
Joanna Jakubowicz-Gil Poland 21 564 1.4× 134 0.8× 93 0.7× 105 1.0× 172 1.7× 55 1.1k
Isabella Dell’Aica Italy 15 396 1.0× 100 0.6× 100 0.7× 118 1.1× 203 2.0× 19 1.0k
Huan Du China 20 613 1.5× 122 0.7× 222 1.6× 73 0.7× 127 1.2× 76 1.2k
Min‐Ho Suh South Korea 20 621 1.5× 156 0.9× 156 1.1× 146 1.4× 65 0.6× 40 1.3k
T.R. Santhoshkumar India 20 702 1.7× 169 1.0× 128 0.9× 114 1.1× 83 0.8× 53 1.2k
Han Yang China 10 479 1.2× 171 1.0× 62 0.4× 154 1.4× 70 0.7× 20 1.0k

Countries citing papers authored by Enlong Ma

Since Specialization
Citations

This map shows the geographic impact of Enlong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Enlong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Enlong Ma more than expected).

Fields of papers citing papers by Enlong Ma

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Enlong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Enlong Ma. The network helps show where Enlong Ma may publish in the future.

Co-authorship network of co-authors of Enlong Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Enlong Ma. A scholar is included among the top collaborators of Enlong Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Enlong Ma. Enlong Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Liu, Xiaofeng, Xinxin Jin, Tianyi Dong, et al.. (2024). Riboflavin protects against pancreatic cancer metastasis by targeting TGF-β receptor 1. Bioorganic Chemistry. 146. 107274–107274. 6 indexed citations
3.
Liu, Xiaofeng, Yuwei Huang, Yanchun Li, et al.. (2024). Sodium cromoglycate exerts anti-pulmonary fibrosis effects by targeting the Keap1 protein to activate Nrf2 signaling. Bioorganic Chemistry. 153. 107961–107961. 3 indexed citations
4.
Zhang, Yi, Xiaohong Xu, Yongzheng Liu, et al.. (2022). Design and synthesis of dual cathepsin L and S inhibitors and antimetastatic activity evaluation in pancreatic cancer cells. Bioorganic & Medicinal Chemistry Letters. 80. 129087–129087. 4 indexed citations
5.
Cao, Zhi, Tong Li, Xinyu Wang, et al.. (2021). Structural and PK-guided identification of indole-based non-acidic autotaxin (ATX) inhibitors exhibiting high in vivo anti-fibrosis efficacy in rodent model. European Journal of Medicinal Chemistry. 227. 113951–113951. 9 indexed citations
6.
7.
8.
Liu, Yutong, Baichun Hu, Jian Wang, et al.. (2019). A novel cathepsin L inhibitor prevents the progression of idiopathic pulmonary fibrosis. Bioorganic Chemistry. 94. 103417–103417. 17 indexed citations
9.
Gu, Xi, Jinling Li, Mingxing Wang, et al.. (2019). Identification of potential platelet-derived growth factor receptor α inhibitors by computational screening and binding simulations. Journal of Molecular Graphics and Modelling. 96. 107527–107527. 4 indexed citations
10.
Yuan, Lei, Jun Liu, Wenhui He, et al.. (2018). Discovery of a novel cathepsin inhibitor with dual autophagy-inducing and metastasis-inhibiting effects on breast cancer cells. Bioorganic Chemistry. 84. 239–253. 12 indexed citations
11.
Liu, Miao, Hanying Xu, Ling Zhang, et al.. (2017). Salvianolic acid B inhibits myofibroblast transdifferentiation in experimental pulmonary fibrosis via the up-regulation of Nrf2. Biochemical and Biophysical Research Communications. 495(1). 325–331. 48 indexed citations
12.
Ma, Enlong, et al.. (2017). Pharmacologic ascorbate induces neuroblastoma cell death by hydrogen peroxide mediated DNA damage and reduction in cancer cell glycolysis. Free Radical Biology and Medicine. 113. 36–47. 60 indexed citations
13.
Li, Wei, Lei Sheng, Chun-Feng Zhang, et al.. (2016). Design, synthesis and biological evaluation of novel asperphenamate derivatives. European Journal of Medicinal Chemistry. 110. 76–86. 15 indexed citations
14.
Liu, Miao, Mingjing Zheng, Hanying Xu, et al.. (2015). Anti-pulmonary fibrotic activity of salvianolic acid B was screened by a novel method based on the cyto-biophysical properties. Biochemical and Biophysical Research Communications. 468(1-2). 214–220. 18 indexed citations
15.
Han, Song Iy, Sizhe Feng, Enlong Ma, et al.. (2014). Glioma cell-derived placental growth factor induces regulatory B cells. The International Journal of Biochemistry & Cell Biology. 57. 63–68. 58 indexed citations
16.
Li, Yanchun, et al.. (2012). JNK-dependent Atg4 upregulation mediates asperphenamate derivative BBP-induced autophagy in MCF-7 cells. Toxicology and Applied Pharmacology. 263(1). 21–31. 51 indexed citations
17.
Lei, Yuan, Yanchun Li, Chao Wang, et al.. (2012). Synthesis and in vitro antitumor activity of asperphenamate derivatives as autophagy inducer. Bioorganic & Medicinal Chemistry Letters. 22(6). 2216–2220. 15 indexed citations
18.
Li, Yanchun, Pengfei Zhang, Feng Qiu, et al.. (2012). Inactivation of PI3K/Akt signaling mediates proliferation inhibition and G2/M phase arrest induced by andrographolide in human glioblastoma cells. Life Sciences. 90(25-26). 962–967. 50 indexed citations
19.
Zhang, Liang, Weige Zhang, Enlong Ma, et al.. (2007). Synthesis and Antiproliferative In‐Vitro Activity of Natural Flavans and Related Compounds. Archiv der Pharmazie. 340(12). 650–655. 7 indexed citations
20.
Tsuneki, Hiroshi, Enlong Ma, Shinjiro Kobayashi, et al.. (2005). Antiangiogenic activity of β-eudesmol in vitro and in vivo. European Journal of Pharmacology. 512(2-3). 105–115. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Xiang Zuo Breakdown of academic impact, for papers by An-Cheng Huang Breakdown of academic impact, for papers by Chunliu Mi Breakdown of academic impact, for papers by Priya Weerasinghe Breakdown of academic impact, for papers by Joanna Jakubowicz-Gil Breakdown of academic impact, for papers by Isabella Dell’Aica Breakdown of academic impact, for papers by Huan Du Breakdown of academic impact, for papers by Min‐Ho Suh Breakdown of academic impact, for papers by T.R. Santhoshkumar Breakdown of academic impact, for papers by Han Yang
Rankless by CCL
2026